HealthDataNavigator Understand strengths and weaknesses of existing data bases and projects

Medical Goods


Medical products and devices are receiving increasing attention from healthcare regulators both from the safety and economic points of view. Indeed, it is mostly  the introduction of innovative products that drives healthcare expenditure up rather than demographic factors themselves. This is why governments are introducing strict health technology assessment procedures through which the industry has to prove both the economic and public health value added of products they wish to introduce on the markets.
Currently, medical products and devices make up for between 11% and 35% of total health expenditure in Europe.
Source: OECD Healthcare Financing Tables 2010

Health Status

Aggregate data

  • Finland: KELASTO database reports the payments for reimbursed drugs, rehabilitation, private health care services,sickness absence day and other special benefits reimbursed by the social security. pfeil zu

Individual level data

  • Finland: The Finnish Health Interview Survey “TERVEYS 2000/2011” and the FINRISK survey administered by THL provide information on self-perceived health, chronic disease and mental conditions, life quality, health impairment in a periodically conducted survey. pfeil zu

Quality (valued outcomes)

Aggregate data

Individual level data

  • Finland: The Finnish Patient Insurance Centre handles the compensation procedures for patient injuries that occur in Finland and maintain a database which includes all these incidents.
  • France: Baromètre Santé is a survey addressing health promotion and harzards prevention issues. It has been carried out since 1992 covering a variety of different themes, e.g. drug prescription for HIV patients. pfeil zu
  • Israel: Individual HMO administrative data - Person level data are collected by four HMOs and covers all Israeli citizens. Data elements are linked by unique identifier, and include information on hospital services, pharmacy purchases, physician visits and laboratory tests and demographic data. Quality measurements can be derived from the linked files pfeil zu

Efficiency/Economy

Physical Inputs (infrastructure)

Aggregate data

  • France: Eco Santé IRDES contains detailed information on the French pharmaceutical infrastructure, i.e. type, quantity and price of drugs sold, number of employees in the pharmaceutical industry, etc.
  • Israel: Israel health services basket by Israeli ministry of health - Detailed data on drugs in Israel, and drugs covered by the national basket of services.
  • Israel: Medical devices registry by ministry of health  [Hebrew]– Detailed data on the medical devices (including devices in pending registration or has expired): name of the device and manufacture, date of approval and expiration.

Activity/Utilization

Aggregate data

  • Austria: Statistics Austria issues data on the consumption of prescribed and non-prescribed medicine by age, gender for years 1999 and 2006/2007.
  • Austria:The “Austrian Health Interview Survey 2006/07” provides detailed information on prescribed and non-prescribed medication by type of medicament, age and region pfeil zu
  • Estonia: State Agency of Medicines collects statistics on all aspects of pharmaceutical care, including the quantity and costs of medicines sold in pharmacies.
  • France: Eco Santé IRDES at the national and regional levels, provides specific statistics data on production in the pharmaceutical industry and relevant data on drugs consumption i.e. type, quantity and price of drugs sold and revenues for chemists/pharmacies.
  • Germany:GBE des Bundes provides tables on the consumption of drugs by ATC-group, in DDD as well as number of prescriptions. Moreover, it contains data on type and quantity (in DDD) of drugs prescribed by type of physician.
  • Germany: The PharmNet.Bund.de portal provides a database of medicinal products that are registered in Germany. Database is compiled from the drug information system of the competent authorities such as Federal Institute for Drugs and Medical Devices (BfArM), Paul-Ehrlich-Institute (PEI) and Federal Office of Consumer Protection and Food Safety (BVL).
  • Israel:  HMOs data – Aggregated data on prescription, purchase and use of drugs and medical devices, as well as drug treatments.
  • United Kingdom: The Office for National Statistics provides data on in- as well as outpatient health care utilization, also that of pharmacy services.
  • United KingdomHES database contains details of all prescriptions to NHS hospitals in England both at the aggregate and individual level.pfeil zu

Individual level data

  • Austria: BIG (Buisness Intelligence in the health care system), a health data pool hosted by the Main Association of Austrian Social Security institutions, is particularly rich on pharmaceutical consumption. pfeil zu
  • France: SNIIR-AM covers all ambulatory care activity in France. It provides patient level data on drugs dispensed along with frequency of consultation, medical procedures and diagnostics method used. The expenditure associated with all these activities is also part of the database. pfeil zu
  • United Kingdom: HES database contains details of all prescriptions to NHS hospitals in England both at the aggregate and individual level. pfeil zu
  • Israel: Individual HMOs data – Person level data on prescription, purchase and use of drugs and medical devices, as well as drug treatments. pfeil zu

Cost and Expenditure

Aggregate data

  • Austria: Statistisches Handbuch der österreichischen Sozialversicherung (Statistical handbook of the Austrian social security) provides annual data on expenditure and prescription by pharmacies, expenditure for auxiliary devices (orthopaedical, optical etc.) since 1991 [in German].
  • Estonia: State Agency of Medicines collects statistics on all aspects of pharmaceutical care, including the quantity and costs of medicines sold in pharmacies.
  • Finland: THL provides a table compatible with SHA tables showing main aggregates of private and public health expenditure and investment and publishes periodically the list of national reference (unit) prices of all important health and social services.
  • Finland:KELASTO database reports the payments for reimbursed drugs, rehabilitation, private health care services,sickness absence day and other special benefits reimbursed by the social security. pfeil zu
  • France: Eco Santé IRDES at the national and regional levels, provides specific statistics data on prescription drugs consumption and associated cost to social security.
  • Germany:GBE des Bundes contains data on pharmaceuticals sales in pharmacies and drugstores since 2001. It provides graphs on per capita spending on OTC drugs and self-medication.
  • Israel: Annually reports on HMOs activity by Israeli ministry of health [Hebrew] – Aggregated data on health expenditures including expenditure on drugs and medical devices.
  • Israel: Price list for all prescription drugs in Israel- by Israeli ministry of health. 
  • United Kingdom: The PSSRU holds data on unit costs of health and social care. Based on administrative data and considers all NHS costs.
  • United Kingdom: PESA collects outturn data, estimated outturn for the latest year and budgetary plans over the whole range of UK public expenditure.

Individual level data

  • Austria: BIG (Buisness Intelligence in the health care system), a health data pool hosted by the Main Association of Austrian Social Security institutions, is particularly rich on pharmaceutical consumption. pfeil zu
  • Finland: The hospital benchmarking database (THL) contains patient level bottom-up based cost accounting data for ca. 30% all hospital inpatient and outpatient care in the country. National DRG cost weights are based on these data. pfeil zu
  • France: SNIIR-AM reimbursement database of the National Health Insurance Fund. Public expenditure in reimbursments of medical goods consumption including reimbursed prescription and OTC drugs consumption, excluding private out-of-pocket payments. pfeil zu
  • Israel: Individual HMOs data –Person level data on prescription, purchase and use of drugs and medical devices, as well as data on drugs and medical devices cost and expenditures at a patient level. pfeil zu
  • United Kingdom: HES database contains details of all prescriptions to NHS hospitals in England both at the aggregate and individual level.pfeil zu

Access/Equity

Aggregate data

Individual level data

  •  Austria: The “Austrian Health Interview Survey 2006/07” provides detailed information on socio-economic factors, such as income, age, occupation, education, citizenship and country of birth and contains information on medication. pfeil zu
  • Austria: FoKo datasets ("Folgekosten-Datenbank") maintained by individual sick funds provide socio-demographic data (age, gender, occupation, income) as well as information on diagnoses and  medication. FoKo datasets are available for three federal provinces only and differ in scope as well as depth of information contained.
  • France: Health, Healthcare and Insurance Survey (ESPS), contains specific information on income and social background and has several questions on access to medical goods, access to drugs in particular. Allows assessing the distribution of consumption. pfeil zu
  • United Kingdom: The British Household Panel Survey (BHPS) has comprehensive information on the socio-economic background and income of the individuals. Information about their households is also available. pfeil zu

Health System Design and Context 

Austria | Estonia | Finland | France | Germany | Israel | Luxembourg | United Kingdom

International Projects & Data

Projects

  • PHIS displays graphically current pharmaceutical expenditure in % of a variety of indicators, such as in % of GDP and total health spending, for a variety of European countries. Moreover, it distinguishes between pharmaceutical spending of the in- and outpatient sector further broken down by each's public and private shares.

Data

  • OECD provides data on the number of pharmacists and their density per 1.000 population, data on total and per capita pharmaceutical spending and on pharmaceutical consumption for various types of drugs (in DDD) for all OECD countries since 1980 pfeil zu
  • WHO provides data on pharmaceutical expenditure, distinguishing public and private as well as total and per capita spending and lists the number of all pharmacists practicing and graduating in a given year for the larger European region since 1980 pfeil zu
  • Eurostat contains data on health care expenditure by providers of medical goods since 2003, in millions, per capita and in % of GDP. It also has data on the relative prices of drugs across European member states. For 2005 see graph thereof on HEIDI Wiki pfeil zu